SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić +7 more
wiley +1 more source
The prognosis value of geriatric nutritional risk index and associated genes in elderly patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy. [PDF]
Zhang Y +9 more
europepmc +1 more source
The NGS and PCR-based Detection of EGFR Mutations in Liquid Biopsy: A Systematic Review and Meta-analysis Compared With Tissue Biopsy in Treatment-naïve Patients With Non-small Cell Lung Cancer. [PDF]
Molina MDSG +3 more
europepmc +1 more source
Skeletal muscle-kidney crosstalk in a cohort of critical illness survivors. [PDF]
Ribeiro HS +11 more
europepmc +1 more source
Hypoxia/lncRNA-AK123072/EGFR pathway induced metastasis and invasion in gastric cancer.
Zhen Yang +3 more
openalex +1 more source
Non-small Cell Lung Cancer in Women: Experience From the National Institute of Oncology, Rabat, Morocco. [PDF]
Cherkaoui B +6 more
europepmc +1 more source
Comparing the effect of traditional and novel tyrosine kinase inhibitors for epidermal growth factor receptor exon 20 insertions by molecular dynamics simulation. [PDF]
Liu KJ +9 more
europepmc +1 more source
Establishment of a Flow Cytometry Protocol for Binarily Detecting Circulating Tumor Cells with EGFR Mutation. [PDF]
Chang CY +11 more
europepmc +1 more source

